Tags Posts tagged with "Power of 3"

Power of 3

A rendering of Suskityrannus hazelae by Andrey Atuchin

By Daniel Dunaief

Even the name Tyrannosaurus rex seems capable of causing ripples across a glass of water, much the way the fictional and reincarnated version of the predator did in the movie “Jurassic Park.”

Long before the predatory dinosaur roamed North America with its powerful jaws and short forelimbs, some of its ancestral precursors, whom scientists believed were considerably smaller, remained a mystery.

A team of scientists led by Sterling Nesbitt, an assistant professor at Virginia Tech, shed some light on a period in which researchers have found relatively few fossils when they shared details about bones from two members of T. rex’s extended ancestral family in New Mexico. 

These fossils, which they named Suskityrannus hazelae, help fill in the record of tyrannosauroid dinosaurs that lived between the Early Cretaceous and latest Cretaceous species, which includes T. rex.

Sterling Nesbitt, assistant professor of geosciences at Virginia Tech, with a partial fossil of Suskityrannus hazelae found in New Mexico. Photo courtesy of Virginia Tech

The researchers, which included Alan Turner, an associate professor of anatomical sciences at Stony Brook University, chronicled the history of these fossils from the Late Cretaceous period, or about 92 million years ago.

“Getting a chance to understand the origin of something is compelling,” said Turner. “Having a discovery like Suskityrannus, which helps us understand how the body plan of tyrannosauroids evolved, is super interesting.” The fossils reveal the “humble beginnings” of a group that would “later dominate North American terrestrial ecosystems.”

Indeed, the new dinosaur was considerably more modest in size than future predators. The Suskityrannus, which included one individual that wasn’t fully grown when it died after living at least three years, measured about three feet at the hip, weighed about 100 pounds, and was about nine feet long, which made it more like a full grown male wolf, albeit longer because of its extended tail.

Scientists had found earlier tyrannosaur relatives from the Early Cretaceous as well as T. rex and its closest relatives near the end of the Late Cretaceous. They were missing data about tyrannosaurs from the middle of the group’s history because fossils from this time period are so rare.

The researchers cautioned that this paper, which was published in the journal Nature, Ecology & Evolution, does not suggest that Suskityrannus was a direct ancestor of T. rex. It does, however, fill a fossil gap in the extended T. rex family.

Suskityrannus hazelae,

The Suskityrannus species has a broad mouth and a muscular skull. Additionally, the bones in its foot were built in a way that made it good at absorbing shocks.

As far as fossil specimens, the bones from this finding are “well represented” across various parts of this creature’s anatomy, including a “lot of limb anatomy and a good portion of the skull and vertebral column,” Turner said. 

This collection of bones help define where on the evolutionary map this new species belong. Some of the anatomical characteristics in this new species appear to be well-suited for future predators, even as they likely also provided an adaptive advantage for the Suskityrannus. 

“These are features that were already in place much earlier” than this new species needed them, Turner said. They may have been adaptations that helped with their agility or with the environment in which they lived. Eventually, evolution turned them into the kinds of anatomical features that made them useful when T. rex eventually grew to as large as 16 tons.

“That’s something you see often in evolution: the way a species is using [its anatomy] isn’t always necessarily what the features evolved for,” Turner said. “Evolution can only work with what it has. What we see with Suskityrannus is that it had these things that became important later on.”

Turner’s role was to help compile and analyze the enormous amount of data that came out of this discovery. He explored how the number of species changed along the boundary between the first half of the Late Cretaceous and the second half of the Late Cretaceous periods, adding that the process of exploring and analyzing such a discovery can take years. 

Indeed, Turner first saw the fossil in 2007. “The studies take a long time and you can get lost in the details,” he said. “You do try and keep the big picture in your head. That’s the thing that makes [the work] interesting.”

Alan Turner while conducting fieldwork in Kenya last summer. Photo by Eric Gorscak

Turner became a part of this work through his connection to Nesbitt. The two scientists attended graduate school together at Columbia University. They have been doing field work together since 2005.

Nesbitt explained in an email that he thought of including Turner immediately “because he is an expert on aspects of paleobiology and theropods, plus he is an excellent colleague to work on papers with.”

In the research paper, the scientists have created an artistic rendering of what this new species might have looked like. While Turner acknowledges that the image involves a “bit of an artistic license,” the image is also “bound by what we know.” 

Nesbitt said this finding provides information about the theropods as a whole. “We really don’t know why T. rex and its closest relatives got so big,” he said, but researchers do know this happened at the end of the Cretaceous period, after 80 million years of being relatively small.

Turner lives in Port Jefferson with his wife, Melissa Cohen, who is the graduate program coordinator in the Department of Ecology & Evolution at Stony Brook University. The couple has two children.

Turner, who grew up in a suburb of Cleveland, recalls a field trip when he was 17 that encouraged him to pursue a career in paleontology. He was conducting research in Montana and he was exploring dinosaurs and sharing a sense of camaraderie with others on the expedition.

“I remember feeling like that was an affirming experience,” Turner said.

As for the discovery of Suskityrannus, Turner shared the wonder at finding a new species, something he’s been a part of eight times with dinosaurs in a career that now includes 11 years at Stony Brook.

“It’s always pretty exciting when you get to work on something that’s new,” he said.

Enyuan Hu with images that represent electron orbitals. Photo from Enyuan Hu

By Daniel Dunaief

Charging and recharging a battery can cause a strain akin to working constantly without a break. Doctors or nurses who work too long in emergency rooms or drivers who remain on the road too long without walking around a car or truck or stopping for food can function at a lower level and can make mistakes from all the strain.

Batteries have a similar problem, as the process of charging them builds up a structural tension in the cathode that can lead to cracks that reduce their effectiveness.

Working with scientists at Brookhaven National Laboratory and the Stanford Synchrotron Radiation Lightsource, Enyuan Hu, an assistant chemist at BNL, has revealed that a doughnut-shaped cathode, with a hole in the middle, is more effective at holding and regenerating charges than a snowball shape, which allows strain to build up and form cracks. 

At this point, scientists would still need to conduct additional experiments to determine whether this structure would allow a battery to hold and regenerate a charge more effectively. Nonetheless, the work, which was published in Advanced Functional Materials, has the potential to lead to further advances in battery research.

“The hollow [structure] is more resistant to the stress,” said Hu. Lithium is extracted from the lattice during charging and changes the volume, which can lead to cracks.

The hollow shape has an effective diffusion lens that is shorter than a solid one, he added.

Yijin Liu, a staff scientist at Stanford’s Linear Accelerator Center (SLAC) and a collaborator on the project, suggested that the result creates a strategic puzzle for battery manufacture.

Enyuan Hu with drawings that represent images of metal 3d orbitals interacting with oxygen 2p obits, forming either sigma bonds (above) or pi bonds (below).
Photo from Enyuan Hu

“On the one hand, the hollow particles are less likely to crack,” said Liu. “On the other hand, solid particles exhibit better packing density and, thus, energy density. Our results suggest that careful consideration needs to be carried out to find the optimal balance.” The conventional wisdom about what caused a cathode to become less effective involved the release of oxygen at high voltage, Hu said, adding that this explanation is valid for some materials, but not every one.

Oxygen release initiates the process of structural degradation. This reduces voltage and the ability to build up and release charges. This new experiment, however, may cause researchers to rethink the process. Oxygen is not released from the bulk even though battery efficiency declines. Other possible processes, like loss of electric contact, could cause this.

“In this specific case of nickel-rich layered material, it looks like the crack induced by strain and inhomogeneities is the key,” said Hu.

In the past, scientists had limited knowledge about cracks and homogeneity, or the consistent resilience of the material in the cathode.

The development of new technology and the ability to work together across the country made this analysis possible. “This work is an excellent example of cross-laboratory collaboration,” said Liu. “We made use of cutting edge techniques available at both BNL and SLAC to collect experimental data with complementary information.”

At this point, Hu estimates that about half the battery community believes oxygen release causes the problem for the cathode, while the other half, which includes Hu, thinks the challenge comes from surface or structural problems. 

He has been working to understand this problem for about three years as a part of a five-year study. His role is to explore the role of the cathode, specifically, which is his particular area of expertise.

Hu is a part of a Battery500 project. The goal of the project is to develop lithium-metal batteries that have almost triple the specific energy currently employed in electric vehicles. A successful Battery500 will produce batteries that are smaller, lighter and less expensive than today’s model.

Liu expressed his appreciation for Hu’s contributions to their collaboration and the field, saying Hu “brings more than just excellent expertise in battery science into our collaboration. His enthusiasm and can-do attitude also positively impacts everyone in the team, including several students and postdocs in our group.”

In the bigger picture, Hu would like to understand how lithium travels through a battery. At each stage in a journey that involves diffusing through a cathode, an anode and migrating through the electrolyte, lithium interacts with its neighbors. How it interacts with these neighbors determines how fast it travels. 

Finding lithium during these interactions, however, can be even more challenging than searching for Waldo in a large picture, because lithium is small, travels quickly and can alter its journey depending on the structure of the cathode and anode.

Ideally, understanding the journey would lead to more efficient batteries. The obstacles and thresholds a lithium ion needs to cross mirror the ones that Hu sees in everyday life and he believes he needs to circumvent these obstacles to advance in his career.

One of the biggest challenges he faces is his comfort zone. “Sometimes, [comfort zones] prevent us from getting exposed to new things and ideas,” he said. “We have to be constantly motivated by new ideas.”

A cathode expert, Hu has pushed himself to learn more about the anode and the electrolyte.

A resident of Stony Brook, Hu lives with his wife, Yaqian Lin, who is an accountant in Port Jefferson, and their son Daniel, who attends Setauket Elementary School.

Hu and Lin met in China, where their families were close friends. They didn’t know each other growing up in Hefei, which is in the southeast part of the country.

Hu appreciates the support Lin provides, especially in a job that doesn’t have regular hours.

“There are a lot of off-schedule operations and I sometimes need to leave home at 10 p.m. and come back in the early morning because I have an experiment that requires my immediate attention. My wife is very supportive.”

As for his work at BNL, Hu said he “loves doing experiments here. It has given me room for exploring new areas in scientific research.”

Sean Clouston

By Daniel Dunaief

Every year, the country pauses on 9/11, remembering the victims of the terrorist attacks and reflecting on the safety and security of the country. At the same time, a Stony Brook University study continues not only to remember the first responders but also to understand the physical and mental consequences of the work police, firefighters and other first responders performed in the immediate aftermath of the attacks.

Benjamin Luft

Recently, Sean Clouston, an associate professor in the Department of Family, Population & Preventive Medicine at SBU Renaissance School of Medicine, and Ben Luft, the director of the SBU WTC Health and Wellness Program since 2003, published research in which they demonstrated a link between a protein commonly connected with Alzheimer’s disease to post-traumatic stress disorder, or PTSD, in first responders.

In a small preliminary study, the researchers found a difference in the level of the protein between first responders who are battling chronic PTSD and those who aren’t battling the condition. The Stony Brook scientists published their work in the journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.

The researchers cautioned that the presence of the markers doesn’t necessarily indicate anything about present or future changes in cognitive function.“We don’t know the specificity of the markers,” Luft explained in an email.

Amyloid is generally considered the earliest marker of Alzheimer’s disease, which includes cognitive decline. Some people, however, have significant amounts of amyloid and don’t develop problems with their thinking. Neurodegenerative diseases without amyloid rarely have severe symptoms, which don’t appear to worsen with time.

“This paper doesn’t look at cognitive symptoms,” Clouston said. “We do have papers looking at cognitive impairment and other memory-based differences. It wasn’t a part of this paper.”

The newest research is part of an ongoing program in which the university follows 11,000 responders who came to the World Trade Center. The study for this paper involved a smaller subset of this population. This type of research can and does have application to other studies of people who have traumatic experiences, the scientists suggest.

Most traumatic experiences are unique to each person, as people who suffer physical and emotional trauma in combat often confront the aftereffects of head injuries. Among the first responder population who survived the attacks on 9/11, most of them “faired pretty well physically,” Clouston said. 

“We didn’t have a lot of head injuries. Understanding PTSD in this crowd is really useful for the literature as a whole because it allows us to focus on the long-term psychiatric fallout of an event without worrying about exposures that are different.”

The scientists had at least some idea of the timing and duration of exposures. This research suggests that it might be helpful to think about the kinds of problems that cognitive impairment can cause, which might involve managing other health-related problems.

Luft added that the population they are studying shows the benefit of immediate care. “One thing for sure is that the care of the first responders has to occur very quickly,” he said. “Now that we know the history, the greatest chance you have in mitigating the effect of this type of trauma is to deal with the problem from the get-go.” 

Sean Clouston with his daughter Quinn at Benner’s Farm in Setaukt. with his daughter Quinn. Photo by Rachel Kidman

First responders have benefited from psychotherapy as well as from various pharmacological treatments. Luft suggested that they might even benefit from having therapists available in the field, where they can receive near instantaneous psychological support.

In addition to the psychological trauma, first responders have had physical effects from their work in the aftermath of the attacks, such as respiratory and gastrointestinal problems, as well as autoimmunity issues.

People have these problems because “of the pro-inflammatory effect of PTSD itself,” said Luft. The researchers believe trauma can affect the immune system and the brain.

According to Clouston, the next step with this work is to replicate it with a larger scale. The experiment was “fairly expensive and untried in this population and novel in general, so we started small,” he explained in an email. The scientists would like to “get a larger range of responders and to examine issues surrounding symptomatology and other possible explanations.”

Clouston has been at Stony Brook for six years. Prior to his arrival on Long Island, he worked on a collaborative project that was shared between University College London and the University of Victoria. 

An expert in aging, he felt like his arrival came at just the right time for the WTC study, as many of the first responders were turning 50. After giving talks about the cognitive and physical effects of aging, he met Luft and the two decided to collaborate within six months of his arrival.

Clouston is focused on whether PTSD caused by the terrorist attacks themselves have caused early brain aging. A self-proclaimed genetics neophyte, he appreciates the opportunity to work with other researchers who have considerably more experience in searching for molecular signatures of trauma.

Clouston said his family has suffered through the trauma of cognitive decline during the aging process. His family’s struggles “definitely bring [the research] home,” reminding him of the “terror that many family members feel when they start noticing problems in their siblings, parents, spouses, etc.”

As for his work on the recent study, he said he is excited about the next steps. “Little is known about the subtypes of amyloid,” he suggested and there’s a “lot more to explore about the role [of this specific type] in the population. I do think it could be really informative about the types of symptoms.”

Alexander Orlov, right, with former students, Peichuan Shen and Shen Zhao. File photo

By Daniel Dunaief

Alexander Orlov knows first-hand about the benefits and dangers of technology. A native of the Ukraine, Orlov and his family lived close enough to Chernobyl that the 1986 nuclear power plant disaster forced the family to bring a Geiger counter to the supermarket. In his career, the associate professor in the Material Science and Chemical Engineering Department at Stony Brook University has dedicated himself to unlocking energy from alternatives to fossil fuels, while he also seeks to understand the environmental consequences of the release of nanoparticles.

Orlov, who is a member of a US-EU working group on Risk Assessment of Nanomaterials and has served as science adviser to several congressmen, the EU Commission and governments in Europe and Asia, recently spoke with Times Beacon Record News Media about this expanding scientific field.

Alexander Orlov File photo

TBR: Is a big part of what you do understanding the way small particles can help or hurt people and the environment?

Orlov: Yes, we have two lines of research. The first is to make efficient nanoparticles, which can help create sustainable energy by creating energy from water or by taking carbon dioxide, which is greenhouse gas, and converting it into fuel. On the other side, we have a project, which is looking at the dangers of nanoparticles in the environment, because there are more and more products, thousands, which contain nanoparticles. We are trying to understand the mechanism of release of those particles.

TBR: How do you monitor the release of nanomaterials?

Orlov: We use labels, and we track them. If they are released from consumer products, it’s not necessarily that they are immediately dangerous. They can be. We are trying to quantify how much is released.

TBR: How do you determine toxicity?

Orlov: In the scientific arena, there is a qualitative discussion, if chemicals or nanomaterials are released, they will be toxic. That is only the beginning. We need to discuss how much is released. There’s a principal in toxicology that everything is toxic. If you drink too much water, it can be toxic and you can die. Similar [rules] apply for nanomaterials. If there is a little released, the danger might be minimal. If it’s too much, that’s where you might get concerned. [The amount of a nanomaterial released] is often not quantified. That’s what we are trying to do.

TBR: How do you determine what might be toxic over a prolonged period of time?

Orlov: What we have in our studies are determined by funding. Normally, funding for scientific research has a three-year window. The studies have been done over the course of years, but not decades, and so the cumulative exposure is still an open question. Another problem is that different scientific groups study nanomaterials which are not the same. That means there are so many variants. Sometimes, navigating the literature is almost impossible.

TBR: Are the studies on toxicity keeping up with the development of new products?

Orlov: [The technology is] developing so fast. New materials are coming from different labs and have so many potential applications, which are exciting and novel in their properties. People studying safety and toxicity often can’t catch up with what they are studying in their lab.

TBR: Are there efforts to recapture nanomaterials released into the environment?

Orlov: Once released, it’s difficult to recapture. [It’s almost] like air pollution, where as soon as it’s in the atmosphere, it can go anywhere. There are industries that use nanomaterials. Soon, you’ll see 3-D printers in the household; 3-D printers would use polymers and embedded nanomaterials. There are already products like this. The question is how you would minimize consumer exposure. There are several ways: design safer products where nanomaterials aren’t going to be released; apply the standard methods of occupational safety; put equipment in ventilated environment; and you can also try to calculate the exposure.

TBR: Are you monitoring nanomaterials in some of these applications?

Orlov: The research we’ve done demonstrated that, even though you have something in polymer or in consumer products, [there is] still [the] possibility of release of nanomaterials, even though it is considered safe. The polymer itself can degrade.

TBR: Do you have any nanoparticle nightmares?

Orlov: Often, the only nightmares I have is that my understanding of the field is so minuscule given that the field is expanding so fast. The amount of knowledge generated and papers published in this is so vast that no single individual can have a comprehensive knowledge in this field. The only way to address it is to collaborate.

TBR: How is the funding environment?

Orlov: In the United States, there’s a significant amount of funding in both fundamental and applied research, but the policy priorities change in certain areas such as environmental protection, so that affects scientists who are working in the environmental area. I teach environmental classes at Stony Brook. Students ask whether it makes sense to go into environmental protection because of the current funding and general policies.

TBR: What do you advise them to do?

Orlov: I tell them priorities change. At the end of the day, would they like to have clean water and a healthy environment and healthy humans? You can find a niche. It doesn’t make sense to abandon this area.

TBR: You experienced the fallout from Chernobyl firsthand. How often do you think about this?

Orlov: I do think about this often for several reasons. There is an overlap in energy and the environment. This idea that scientific discoveries have positive and negative impacts on humanity came during that time. When I was in the Ukraine and disaster happened, I think about this a lot of times.

TBR: How does a career in science compare to your expectations?

Orlov: My original thinking is that after you get to a certain level, you have a more measured life, in terms of free time and time spent in research. I didn’t realize that the amount of funding or probability of getting funding is becoming very low. When I looked at my colleagues who were scientists 30 years ago, they had a five times higher chance of getting funding compared to right now. Being in science is not as relaxing and it can be stressful and the thing is, if you only focus on getting funding, the creativity can suffer.

TBR: Are there other examples of the dichotomy between scientific promise and destruction?

Orlov: In my introductory lecture to chemical engineers at Stony Brook, one scientist who affected more people than Stalin or Hitler was a German scientist who developed the process of converting nitrogen [gas] to ammonia [which is used for fertilizer]. Half of the population exists because of this scientific discovery. [One of the inventors, Fritz Haber, received the Nobel Prize in Chemistry in 1918 for this work, called the Haber-Bosch process].

TBR: What else did he do?

Orlov: Haber had a dark side to him. He was involved in developing chemical weapons for Germans [which were used during World War I and World War II]. The [extension of his] discoveries killed millions of people [including Haber’s relatives in World War II after he died]. Considered the father of chemical warfare, he developed the process of weaponizing chlorine gas. This is [a way] to discuss the ethics of scientific discovery.

TBR: How would people learn about these examples?

Orlov: Stony Brook and other universities are trying to teach ethics to engineers and scientists because this is a perfect example of the dark side of science and how science and policy overlap.

Staff from Brookhaven National Laboratory and Germany’s Centre for Advanced Materials during a recent meeting to discuss a future collaboration, from left, Oleg Gang, group leader for Soft and Bio Nanomaterials; Norbert Huber, the director of the ZHM; Charles Black, the director of the CFN; Patrick Huber, a principal investigator; Priscilla Antunez and Dario Stacchiola, group leader for the Interface Science and Catalysis team. Photo by Joseph Rubin/BNL

By Daniel Dunaief

Priscilla Antunez is a scientist with some unusual expertise. No, she doesn’t run experiments using a rare or expensive piece of equipment; and no, she hasn’t developed a way to understand the properties of unimaginably small particles that assemble themselves and may one day help run future technology.

What Antunez brings to the Center for Functional Nanomaterials, or CFN, at Brookhaven National Laboratory is a background in business. That puts her in a position to help the scientists who run experiments at the CFN or the researchers at BNL, or elsewhere, who study the properties of catalysts or self-assembling small materials.

“This opportunity for me is a maximization of my impact on science,” said Antunez, who joined BNL from Illinois’ Argonne National Laboratory in December. If she were to run her own lab, she would be involved in a project or a handful of projects. “[At BNL] I have the opportunity to help many scientists with their work,” she said.

Priscilla Antunez Photo by Joseph Rubin/BNL

Her assistance will take numerous forms, from acknowledging and celebrating the science the 30 researchers at the CFN and the 600 scientists from around the world who visit the center perform, to developing broader and deeper partnerships with industry.

Her long-term goal is to build a strategy around specific projects and establish partnerships to advance the science and technology, which might include industry.

“We are trying to make [the information] widely available to everyone,” Antunez said. “We are proud of what they’re doing and proud of how we’re helping them accomplish their goals. We’re ultimately getting their science out there, helping them with viewership and readership.”

She is already writing the highlights of scientific papers, which she hopes to share widely.

In addition to sending research updates to the Department of Energy, which sponsors the BNL facility, Antunez will also try to broaden the audience for the research by sharing it on LinkedIn, posting it on the website, and, in some cases, sending out email updates. The LinkedIn page, for now, is by invitation only. Interested readers can request to join at https://www.linkedin.com/groups/8600642.

Antunez takes over for James Dickerson, who has become the first chief scientific officer at Consumer Reports, where he leads the technical and scientific aspects of all activities related to CR’s testing and research, including food and product safety programs. Antunez and Charles Black, the director of the CFN, decided to expand Antunez’s role as assistant director.

Her job is “to help the CFN develop its overall strategy for making partnerships and nurturing them to be successful and have impact,” Black explained in an email.

“For the CFN to thrive in its second 10 years of operations will require us to form deeper relationships with scientific partners, including CFN users, research groups around the world, industries and other national labs,” he said.

Indeed, Black, Oleg Gang, who is the group leader for Soft and Bio Nanomaterials, Dario Stacchiola, the group leader for the Interface Science and Catalysis team, and Antunez recently met with Norbert and Patrick Huber, from Hamburg’s Centre for Advanced Materials.

“We had group and individual discussions to explore complementary areas of research,” said Antunez.

After scientists from the centers meet again to develop research plans, she can “help as much and as early as the CFN scientists need.” She can also coordinate between the CFN and the Contracts Office if the center needs a Cooperative Research and Development Agreement.

The scientist encourages CFN scientists to visit whenever they believe they have an idea that might have an application. She’s had meetings with the Tech Transfer Office and CFN groups and is hoping to put more such gatherings on the calendar.

The CFN is continuing to grow and will be adding five or six new scientific staff positions, Black said. Antunez will “oversee a strategy that helps all CFN staff form deep, productive partnerships that produce new nanoscience breakthroughs.

Black explained that it was an “exciting, challenging, important job and we’re thrilled to have someone as talented and energetic as [Antunez] to take it on.”

Indeed, Antunez was such an effective researcher prior to venturing into the business world that the CFN had tried to hire her once before, to be a postdoctoral researcher in the area of self-assembly. At that time, Antunez had decided to move toward business and took a job at Argonne National Laboratory. “In the end it has worked out well for CFN, because [Antunez] gained valuable experience at Argonne that she has brought to BNL and is using every day,” said Black.

The CFN has divided the work into five groups, each of which has a team leader. Antunez is working on their current partnerships and recruiting needs. She meets with the group leaders during regular management meetings to discuss overall plans, work and safety and the required reports to the DOE.

Antunez lives in Mineola with her husband, Jordan S. Birnbaum, who is the chief behavioral economist at ADP. When she was in college at Universidad de Sonora, Antunez wanted to double major in science and contemporary dance. At the public university in Mexico at the time, she had to choose one or the other, despite an invitation from one of the founding professors of the school of dance to major in dance.

Nowadays, Antunez, who earned her doctorate in chemistry from the University of Southern California, goes to the gym and takes yoga and dance classes, but doesn’t study the art form anymore.

With her science background, Antunez anticipated becoming a teacher. Her current work allows her to share her expertise with scientists. She has also been able to work with some postdoctoral researchers at BNL.

As for her work, Antunez appreciates the opportunity to build connections between scientists and industry. “Most of our technologies are on the basic research side and so the partnerships are much more fluid, which gives us a lot more flexibility in terms of our strategic partners,” she said.

Tobias Janowitz with research technician Ya Gao at Cold Spring Harbor Lab Photo by ©Gina Motisi, 2019/CSHL

By Daniel Dunaief

It’s a low-tech setting with high stakes. Scientists present their findings, often without slides and pictures, to future colleagues and collaborators in a chalk talk, hoping faculty at other institutions see the potential benefit of offering them an employment opportunity.

For Tobias Janowitz, this discussion convinced him that Cold Spring Harbor Laboratory was worth uprooting his wife and three young children from across the Atlantic Ocean to join.

Chalk talks in most places encourage people to “defend their thinking. Here, it was completely different. They moved on from my chalk talk quickly,” said Janowitz in a recent interview.

Research technician Ya Gao and Tobias Janowitz at Cold Spring Harbor Lab. Photo by ©Gina Motisi, 2019/CSHL

Janowitz recalled how CSHL CEO Bruce Stillman asked him “what else will you do that’s important and high risk. He moved me on from that discussion within five minutes and essentially skipped a step I’d usually spend at another institution. It’s a very special place.”

Janowitz, who earned a medical degree and a doctorate from the University of Cambridge, came to the lab to work in a field where he’s distinguished himself with cancer research that points to the role of a glycoprotein called interleukin 6, or IL-6, in a specific step in the progression of the disease, and as a medical oncologist. He will work as a clinician scientist, dedicated to research and discovery and advancing clinical care, rather than delivering standard care.

As CSHL continues to develop its ongoing relationship with Northwell Health, Janowitz said he expects to be “one of the intellectual bridges between the two institutions.”

In his research, the scientist specializes in understanding the reciprocal interaction between a tumor and the body. Rather than focusing on one type of cancer, he explores the insidious steps that affect an organ or system and then wants to understand the progression of signals and interactions that lead to conditions like cachexia, in which a person with cancer loses weight and his or her appetite declines, depriving the body of necessary nutrition.

CSHL Cancer Center Director David Tuveson appreciates Janowitz’s approach to cancer.

“Few scientists are ready to embrace the macro scale of cancer, the multiple organ systems and body functions which are impaired,” Tuveson said. Janowitz is “trying to understand the essential details [of cachexia and other cancer conditions] so he can interrupt parts of it and give patients a better chance to go on clinical trials that would fight their cancer cells.”

A successful and driven scientist and medical doctor, Janowitz “is very talented and could be anywhere,” Tuveson said, and was pleased his new colleague decided to join CSHL.

Janowitz suggested that the combination of weight loss and loss of appetite in advancing cancer is “paradoxical. Why would you not be ravenously hungry if you’re losing weight? What is going on that drives this biologically seemingly paradoxical phenomenon? Is it reversible or modifiable?”

At this point, his research has shown that tumors can reprogram the host metabolism in a way that it “profoundly affects immunity and can affect therapy.” Reversing cachexia may require an anti-IL-6 treatment, with nutritional support.

As he looks for clinical cases that could reveal the role of this protein in cachexia, Janowitz has seen that patients with IL-6-producing tumors may have a worse outcome, a finding he is now seeking to validate.

At this point, treatment for other conditions with anti-IL-6 drugs has produced few side effects, although patients with advanced cancer haven’t received such treatment. Researchers know how to dose antibodies to IL-6 in the human body and treatment intervals would last for a few weeks.

Scientists have long thought of cancer as being like a wound that doesn’t heal. IL-6 is important in infections and inflammation.

Ultimately, Janowitz hopes to extend his research findings to other diseases and conditions. To do that, he would need to take small steps with one disease before expanding an effective approach to other conditions. “Are disease processes enacting parts of the biological response that are interchangeable?” he asked. “I think that’s the case.”

Eventually, Janowitz hopes to engage in patient care, but he first needs to obtain a license to practice medicine in the United States. He hopes to take the steps to achieve certification in the next year.

He plans to gather samples from patients on Long Island to study cancer and its metabolic consequences, including cachexia.

Several years down the road, the scientist hopes the collaborations he has with neuroscientists can reveal basic properties of cancer.

Tuveson believes Janowitz has “the potential of having a big impact individually as well as on everyone around him,” at Cold Spring Harbor Laboratory. “We are lucky to recruit him and want him to succeed and solve vexing problems so patients get better.”

Janowitz lives in Cold Spring Harbor Laboratory housing with his wife Clary and their three children, Viola, 6, Arthur, 4, and Albert, 2.

Clary is a radiation oncologist who hopes to start working soon at Northwell Health.

The Janowitz family has found Long Island “very welcoming” and appreciates the area’s “openness and willingness to support people who have come here,” he said. The family enjoys exploring nature.

The couple met at a production of “A Midsummer Night’s Dream,” which was performed by a traveling cast of the Globe in Emmanuel College Gardens in Cambridge, England.

As with many others, Janowitz has had family members who are living with cancer, including both of his parents. His mother has had cancer for more than a decade and struggles with loss of appetite and weight. He has met many patients and their relatives over the years who struggle with these phenomena, which is part of the motivation for his dedication to this work.

Most cancer patients, Janowitz said, are “remarkable individuals. They adjust the way that they interact with the world and themselves when they get life changing diagnoses.” Patients have a “very reflected and engaged attitude” with the disease, which makes looking after them “incredibly rewarding.”

From left: Carl Safina, Larry Swanson and Malcolm Bowman. Swanson who died Oct. 17, was renowned not only for his work at SBU, but also his kindly demeanor. Photo from Stony Brook University

By Daniel Dunaief

Larry Swanson has led research teams over far-flung water bodies, worked for the National Oceanic and Atmospheric Administration as a commissioned officer for 27 years and has been a fixture at Stony Brook University for over three decades. 

A former dean at the School of Marine and Atmospheric Sciences at SBU and current professor, Swanson, who is a member of New York’s Ocean Acidification Task force, was recently interviewed by Times Beacon Record News Media about his life in science.

TBR: How has science changed over the years?

Swanson: Some of the most significant things are the electronic tools that we have today. If you go back to when I was starting, if you wanted a water sample, and to collect temperature at five miles deep in the ocean, it was a very, very long tedious process. 

When you got that water sample on deck, if you wanted to simply measure salinity, you had to do a chemical titration. If you were doing that over five miles deep, below the first 1,000 meters, you might take a sample every half a mile or something like that. You couldn’t take a lot of samples. 

Now, you lower an instrument and you get a continuous trace of temperature, salinity, dissolved oxygen and other parameters, every few tenths of a meter. We are sort of overwhelmed with data now.

TBR: That must change the way people conduct experiments.

Swanson: When I first started, every data point you collected was extremely valuable and if you lost it, you really lost a lot of time, a lot of energy. It was something you could never recover. With modern instrumentation, you can do so much more and do much of it remotely; you don’t have to go to sea for seven or nine months to do that.

TBR: What are some of the biggest discoveries in your field?

Swanson: This is not necessarily things I have done. The theory of plate tectonics was established. We drilled through the crust of the earth to the mantle and we have discovered hydrothermal vents. We’ve got enough data now that we’re collecting through satellites, direct measurement in oceans in more detail, that we can really talk about changes in the global environment, whether it’s temperature increase, carbon dioxide increase and so forth. 

Those are all things that have taken place over my lifetime in oceanography. We can see what we’re doing to ourselves much more clearly today because of new technology.

TBR: What is one of the great debates in science today?

Swanson: I think trying to understand the impacts of climate change is at the forefront for everyone that’s dealing with ocean and atmospheric sciences. We don’t know all the answers and we haven’t convinced everyone it’s an issue. 

Whether or not it’s driven by people, that [debate] will continue for years to come. We’re going to bear some of the consequences of climate change before we’ve adequately convinced people that we’ve got to change our lifestyle.

TBR: What about local challenges?

Swanson: The notion of ocean acidification and how rapidly it’s changing is a local challenge. What will the consequences of it be if we don’t try to ameliorate it and what do we need to do in order to make it less of a problem? How are we going to build resiliency and reverse it?

TBR: Is there a scientific message you wish people knew?

Swanson: Scientists in general do not communicate well with the public and part of the problem is because we speak in jargon. We don’t talk to [the public] in proper ways that meet their level of understanding or knowledge. We’ve done that poorly. 

For another thing, scientists can be faulted with regard to developing policy. The scientists’ work is never done. If you go to Congress and they ask, “What are we going to do to fix the problem?,” scientists will say, “Give me more money for research and I’ll get back to you.” 

So, there’s a disconnect in terms of time frames over which we operate. [Members of Congress] operate 2 to 4 years out, while scientists operate sometimes over lifetimes. We haven’t been able to bridge that gap.

TBR: Is that improving at all?

Swanson: One of the great things that Stony Brook now has is the Alan Alda Center for Communicating Science, which is helping all the scientists here that are willing to participate in trying to do a better job of communicating. It’s making a difference and having an impact that is meaningful. It’s always good to try to put your science in the most simplistic terms possible, even if it’s a drawing or cartoon that’s helpful.

TBR: What are your future goals?

Swanson: I am hopeful  the new task force can come up with a meaningful ocean acidification action plan. I’m very pleased to be part of that group.

TBR: If you were to start your oceanography career today, what would you do differently?

Swanson: If I were to start over, I would get a master’s degree in oceanography, not a doctorate, and then I would try to get an environmental law degree. The reason I would probably do that is that I think environmental law is the best way to make an immediate impact on society. I firmly believe that one should not be an environmental lawyer until one is a fairly good scientist.

TBR: How many more years before you retire?

Swanson: I’d say a maximum of three and a minimum of one. I’m often asked, “Why are you still working?” First of all, I enjoy it and I think one of the exciting things about being an oceanographer is that there’s never been a dull day. 

Hyunsik Kim and Erin Kang. Photo from Matthew Lerner’s lab

By Daniel Dunaief

This is the second half of a two-part series on autism research conducted by Hyunsik Kim and Erin Kang.

 Last week we focused on the work of Stony Brook University graduate student Hyunsik Kim, who used three criteria to diagnose autism. This week we will feature the work of another SBU graduate student in the Department of Psychology, Erin Kang, who specifically explored the types and severity of communication difficulties autistic children have. 

Words and the way people use them can offer clues about autism. Looking closely at pronoun reversals, speech delays, perseveration and 10 other characteristics, Kang determined that the number of features was a “powerful predictor of an autism spectrum disorder diagnosis.” 

In a paper published online in the Journal of Clinical Child & Adolescent Psychology, Kang grouped children from 6 to 18 years old into different subgroups based on their communication patterns and used a statistical method that allows the data to “speak for itself,” in terms of finding groups based on the patterns of how the communication difficulties are associated and to classify them.

According to Kang, heterogeneity is an important feature of autism spectrum disorder. “There has been a greater effort into understanding whether subgroups exist in ASD populations,” she explained in an email. By examining the atypical communication characteristics, she found four subgroups. These groups differed from each other, not only with autism, but on multiple measures, including the occurrence of anxiety or depression and with intellectual disabilities.

The communication difficulties occur at different rates within the autism children throughout Long Island that Kang studied.

Kang said her work has been “building on the previous literature,” although many of the previous studies focused on characterizing autism for children who were younger than 6.

“There are few studies on specific symptoms (e.g., stereotyped speech) across the body of literature,” she explained, adding that she’s passionate about exploring the trajectory of development over time with or without intervention. 

She and her co-authors, Ken Gadow and Matthew Lerner, who are also at Stony Brook University, are working on a follow-up paper that attempts to explore how changes in the pattern of communication challenges examined in the paper relate to other clinical aspects and outcomes.

Kang believes her results have clinical implications that will help in understanding autism. Atypical communication features are a good predictor of diagnostic status. “This can provide an advantage in assessing social communication profiles in autism,” she said. “It’s hopefully valuable in a low-resource setting.”

Parents might be asked 13 questions on a checklist, which could serve as an initial screening for more comprehensive autism evaluations, rather than a multiple checklist that could take a while for parents to complete. The different categories had specific features that distinguished them. 

“There’s been quite a bit of work in the speech and language field,” said Lerner, an associate professor of psychology, psychiatry and pediatrics in the Department of Psychology at Stony Brook University and Kang’s mentor. “This approach allowed us to ask about some of the specific types of language differences we often see.”

Lerner said what Kang found is that specific characteristics do tend to cluster together in “interesting and unique ways that can tell us more about the communicative phenotype of autism.”

One of the groups, which she called “little professors,” had speech patterns with considerable perseveration. In perseveration, a person repeats a word or phrase, even when a question or stimulus that might elicit that phrase no longer continues. As an example, Dustin Hoffman in the movie “Rain Man” frequently repeated the number of minutes until Judge Wapner was on TV.

“These kids would benefit more from a group-based social skills intervention that specifically integrated interacting with peers,” Kang said. People in this group had the highest percentage of wanting a friend, but difficulty with relating to peers.

“They will benefit especially from interventions that help them build skills in interacting with peers,” she explained.

She also suggested that the best way to make a reliable diagnosis is to collect as much information as possible, which could include observations and electrophysiological data.

Kang acknowledged that some of the responses from the parents or teachers of people with autism contain bias. “There can be a lot of potential especially in terms of these subjective measures,” she said.

Indeed, through Lerner’s lab, Kang has been trying to include more uses of neurological measures and other methodology that is less subject to biases.

“Hopefully, by looking at these more objective measures, we can help integrate information from these different levels,” she said.

A resident of East Northport, Kang lives with her husband, musician Sungwon Kim, who works as a freelancer on Broadway musicals. The couple, who have a young son, met in Boston when she was working at Boston Children’s Hospital and he was a student at Berklee College of Music. 

Kang’s first experience with autism was in high school, when she acted as a mentor to a second grader. When she entered college at the University of California at Berkeley, she studied molecular and cellular biology and psychology.

Lerner said that Kang is a “truly remarkable young scholar” and is “among the best I’ve seen at her stage to be able to look at her clinical experiences, which drive the questions that strike at the core of how we understand and treat autism.”

Lerner appreciates how she is driven to understand autism from neurons in the brain all the way up to the classification and treatment.

“She is somebody who is completely undaunted by taking on new questions or methodologies because she has an idea of what they’re going to mean,” Lerner said. “She has worked with [autistic children] and has tried to understand where they are coming from.”

Kang questions assumptions about what autism is, while also exploring its development.

“She is able to see and discover clinical strengths that manifest in the kinds of questions she asks,” explained Lerner. “She is a part of the next generation of where my field is going, and I hope we can catch up to her.”

Kang appreciates the work-life balance she has struck on Long Island, where she feels like the pace of life is “quiet and calm during the week,” while it’s close enough to New York City to enjoy the cultural opportunities.

From left, Hyunsik Kim, Associate Professor Matthew Lerner and Erin Kang. Photo from Lerner’s lab

By Daniel Dunaief

This is part one of a two-part series on autism research conducted by Hyunsik Kim and Erin Kang.

If someone in a family behaves in ways that are difficult to understand, the family might look for a support group of people with similar characteristics, visit a doctor or seek to document and understand patterns.

Finding a doctor who has seen these types of behaviors, speech patterns or actions before could provide comfort, as the physician may either engage in a course of treatment or provide context and understanding for the current behaviors. The doctor may also offer advice about any likely changes in behaviors in the near or distant future.

For researchers, understanding a range of symptoms, some of which might be below the threshold to meet a specific diagnosis, can lead to a more specific awareness of a condition, which could help guide patients toward an effective treatment.

Hyunsik Kim and Erin Kang, graduate students in the Department of Psychology at Stony Brook University, recently published papers examining autism, hoping to get a more specific understanding of subtle differences and symptoms.

Kim was looking for a better way to conceptualize autism. He used advanced statistical methods to compare three theoretical perspectives to find the one that best characterized the symptoms.

“According to my study, autism is not an all-or-nothing phenomenon, but is dimensional [and is] comprised of three related spectra of behaviors,” he explained. 

Researchers can characterize everyone’s autism symptoms through a combination of levels in each domain.

Each of these three areas can range from very mild to severe.         As an analogy, Kim suggested considering the quality of being introverted. A person can be mildly, moderately or highly introverted, which offers a continuum for the dimension of introversion.

In a dimensional approach that involves exploring these three different categories, researchers can get a better understanding of the symptom profiles.

“For decades, people thought of autism as purely categorical,” said Matthew Lerner, an associate professor of psychology, psychiatry and pediatrics in the Department of Psychology at Stony Brook University. “You either have it or you don’t. In fact, autism was thought of as the easiest diagnosis to make.”

Kim, however, has “a goal of answering the fundamental question: what are we talking about when we’re talking about autism?” Lerner said. “Slowly, autism has morphed from the most categorical to the most dimensional. Literally, people talk about the spectrum when they talk about autism.”

With a dimensional approach based on levels of the three major domains for diagnosing autism, Kim suggested that researchers and doctors could better understand people who fall just below the current diagnosis for autism.

“It’s especially important to identify individuals who show a borderline range of symptoms, who barely fail to meet the diagnostic criteria of a given disorder, and provide them with appropriate treatments,” Kim explained.

Ideally, he hopes a dimensional approach incorporates the severity of symptoms into the current diagnostic system to promote better treatment procedures and outcomes.

Kim recognized that he could have just as easily created a dimensional approach that incorporates a greater number of criteria. His statistical analysis, however, revealed that the three dimensions provide the parsimonious explanation about autism symptoms.

Kim analyzed data from a parent questionnaire. He recognized that self-reporting by parents may underestimate or overestimate the severity of symptoms. He believed the over and under estimate of symptoms likely “evened out.”

Lerner suggests this multidimensional approach has numerous implications. For starters, it can help capture more of the types of symptoms in a diagnosis. It can also highlight the specific area of autism a clinician might want to target.

“We should be focusing on the factors that are most relevant for the individual and which are getting in their way,” Lerner said.

Treating autism broadly, instead of focusing on specific symptoms, may be “misguided,” Lerner added. A more specific characterization of autism could also help advance the field of neurogenetic research. “With more contemporary genetic analysis, we can use findings like this as a road map for what those genetic differences mean,” he said.

For his next step, Kim hopes to expand this work to observational data, adding that to the existing pool of information from parental questionnaires.

“People go on a home visit and take video of autistic kids interacting with others,” Kim said. “We can have some people code their behavior.”

More broadly, Kim would like to answer fundamental questions about the classification and conceptualization of mental disorders by using advanced quantitative modeling and other data-driven approaches. He believes a factor may represent a person’s vulnerability to developing a specific mental disorder.

A high level of this factor, combined with life stressors or adversity, would make it more likely that a person develops a disorder. As someone who studies psychology, Kim said he is well aware of his own emotional patterns and he tries to use his training to help himself cope.

He is not particularly comfortable doing public speaking, but he tells himself that whatever anxiety he feels is normal and that his practice, knowledge and expertise should allow him to succeed.

A resident of Middle Island, Kim lives with his wife Jennifer. The couple has two young children. Kim describes his wife as a “really good” amateur baker, who bakes cakes, muffins, cookies, macaroons, chiffon cakes and more. He has encouraged her to start her own YouTube channel and one day they hope to open a bakery that is online and offline.

As for his autism work, he hopes the dimensional approach is “incorporated into the assessment stage so that individuals do not merely receive a diagnosis, but are informed of their unique symptom profiles, so that clinicians can take them into consideration.” 

Markus Seeliger with a model of a protein kinase. Photo from SBU

By Daniel Dunaief

They are like couples looking for each other on a dating website. Each side could theoretically find a range of connections. The focus in this dating game, however, has heavily favored understanding the preferences of one side. 

Markus Seeliger, an associate professor in the Department of Pharmacological Sciences at the Stony Brook University Renaissance School of Medicine, has taken important steps to change that, albeit in a completely different area. Instead of working with two people who are searching for a date, Seeliger studies the interactions among protein kinases, which are like switches that turn on or off cellular signals, and inhibitors, which researchers and drug companies are creating to slow down or stop the progression of diseases.

Markus Seliger

Most scientists have looked at the pairing of these molecules and protein kinases from the perspective of the inhibitor, trying to figure out if it would bind to one of the 500 protein kinases in the human body.

Seeliger, however, is exploring the coupling from the other side, looking at the selectivity of the kinases. He published recent research in the journal Cell Chemical Biology.

“People have only ever looked at the specificity from the point of view of an inhibitor,” Seeliger said. “We’ve turned it around. We’re looking at it from the perspective of kinases,” adding that kinases have been important drug targets for decades.

In an email, Michael Frohman, a SUNY distinguished professor and the chair of the Department of Pharmacological Sciences, applauded Seeliger’s efforts and said his research “is representative of the innovative work going on in many of the labs here.” 

On a first level, Seeliger discovered eight kinases that bind to a range of potential inhibitors, while the others are more selective.

Within the smaller group that binds a range of inhibitors, there was no sequence relationship between the base pairs that formed the kinases. The kinases are also not closely related in the cellular functions they regulate. They all trigger similar signaling cascades. 

Seeliger wanted to know why these eight kinases were four to five times more likely to couple with an introduced inhibitor than their more selective kinase counterparts. The Stony Brook scientist performed a three-dimensional analysis of the structure of one of these kinases at Brookhaven National Laboratory.

“They have a very large binding pocket that can accommodate many different inhibitors,” Seeliger said. Indeed, he discovered this higher level of receptivity by separating out this group of eight, which also had more flexible binding sites. If the match between the configuration of the inhibitor and the kinase isn’t perfect, the kinase can still find a way to allow the molecule to connect.

For any potential inhibitor introduced into the human body, this more flexible and accommodating group of kinases could cause unintended side effects regardless of the level of specificity between the inhibitor or drug and other targets. This could have health implications down the road, as other researchers may use the properties of these kinases to switch off programs cancer or other diseases use to continue on their destructive paths.

“Studies point to the roles of protein kinases as driving (to at least allowing and permitting) cancer growth and development,” Yusuf Hannun, the director of the Stony Brook University Cancer Center, explained in an email. “Therefore, one needs to inhibit them.”

Hannun described Seeliger as “very rigorous” and suggested he was an “up and coming scientist” whose “novel approach” shed significant new light on protein kinases.

In his research, Seeliger’s next step is to look at the existing database to see what other groups of kinases he finds and then determine why or how these switches have similarities to others in other systems or regions of the body.

Seeliger likened kinases to a control panel on a space shuttle. “Nothing about the sequence tells you about the role of the switches,” which would make it difficult for astronauts to know which switch to turn and in what order to bring the shuttle home.

Another question he’d like to address involves a greater understanding of the complexity of a living system. So far, he’s looked at properties of these kinases under controlled conditions. When he moves into a more complex environment, the inhibitors will likely interact and yield unexpected binding or connections.

Frohman appreciated Seeliger’s overall approach to his work and his contribution to the field. He cited the popularity of a review article Seeliger wrote that documents how drug molecules find their target binding site. Frohman said this work, which was published in the Journal of the American Chemical Society, was cited over 400 times in other articles.

Seeliger has been “very dedicated to moving this field forward. We were very excited about the topic and have been very pleased with the work he’s done on it since arriving at SBU,” Frohman said.

A resident of Stony Brook, Seeliger lives with his wife Jessica Seeliger, an assistant professor in the Department of Pharmacological Sciences who works on developing drugs for tuberculosis. The couple has two young children.

“We are all very happy they are both here as independent scientists,” Frohman added.

Indeed, Hannun called Jessica Seeliger an “outstanding and highly talented scientist,” as well.

Seeliger grew up in Hanover, Germany. He became interested in science in high school when he watched “The Double Helix,” which showed the development of the structural model of DNA.

His lab currently has two postdoctoral researchers and two doctoral candidates. Ultimately, Seeliger hopes his research helps establish an understanding of the way various kinases are functionally similar in how they interact with drugs.

“We wish we would be able to design more specific inhibitors without having to test dozens and dozens of compounds by trial and error,” he explained. He hopes to continue to build on his work with kinases, including exploring what happens when mutations in these switches cause disease.